-
Endpoints That Matter: Integrating Patient-Relevant Outcomes in HTA
-
Creating Defensible Evidence With External Control Arms
-
September 23-24: Evaluation of Digital Health Technologies, Medical Devices, and Pharmaceuticals and the Challenges to Consider - Virtual
-
ISPOR Healthcare Investment Summit 2026
, San Francisco, CA | USA
The ISPOR Healthcare Investment Summit 2026 is the must-attend health economics and outcomes research (HEOR) and real-world evidence (RWE) event in San Francisco. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.
-
September 14-17: Introduction to Health Economics and Outcomes Research - Virtual
-
September 6: Budget Impact Analysis in Practice: A Hands-On Course in Strategic Conceptual Design, Model Building, and Communication - In Person at ISPOR Asia Pacific Summit 2026
-
September 6: Practical Applications of Large Language Models for Real-World Evidence Generation and HEOR - In Person at ISPOR Asia Pacific Summit 2026
-
September 6: Applied Generative AI for HEOR: Introduction - In Person at ISPOR Asia Pacific Summit 2026
-
ISPOR Asia Pacific Summit 2026
, BANGKOK | THAILAND
The ISPOR Asia Pacific Summit 2026 convenes leading experts, policymakers, industry innovators, and patient organizations to explore how health economics and outcomes research (HEOR) advances affordable access to healthcare innovation across the region.
-
Whole Health Evaluation of Multi-System Risk: GLP-1 Insights
-
When Evidence Drives Adoption: How Investors Evaluate Diagnostic, Device, and MedTech Innovation in a Policy Constrained Market
-
HEOR Career Development for New Professionals: Things I Wish I Knew
-
ISPOR Top 10 HEOR Trends - What Are The Key Themes for 2026-27?
-
Harnessing AI to Transform HEOR and Real‑World Evidence Generation in Rare Diseases: Regulatory Expectations, Opportunities, and Practical Use Cases
-
Designing for Access: Early Integrated Evidence Generation Planning in the Era of Expanded Value Frameworks
-
Beyond the Research Assistant: Innovative Uses of AI in Health Preference Research
-
June 24-25: Going Beyond the Standard: Exploring Advanced Survival Modeling Techniques - Virtual
-
Understanding the First JCAs: Practical Takeaways for Key Stakeholders
-
From Evidence to Access: Applying HEOR and Economic Evaluation in Healthcare Decision-Making
-
Delphi or Not Delphi: Selecting the Appropriate Expert Elicitation Approach